Rigel Pharmaceuticals Inc (RIGL) — Cash Flow Quality Index
Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow Quality Index of 1.77x as of June 2026. Operating cash flow of $30.65 Million exceeds net income of $17.29 Million, indicating high earnings quality where cash backs reported profits. Explore Rigel Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Rigel Pharmaceuticals Inc Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for Rigel Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Rigel Pharmaceuticals Inc.
Annual Cash Flow Quality Index for Rigel Pharmaceuticals Inc (2010–2025)
Year-by-year earnings quality comparison for Rigel Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $75.66 Million | $367.02 Million | ▼ -88.5% |
| 2024 | 1.80x | $31.47 Million | $17.48 Million | ▲ +45.9% |
| 2010 | 1.23x | $46.74 Million | $37.89 Million | — |